Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.
Academic rigor, journalistic flair
Articles on Leishmaniasis
Displaying all articles
Kala-azar, already one of the most neglected diseases on the planet, is in danger of becoming even more neglected.
Many of these diseases cause tremendous suffering and death – yet there’s still a lack of effective tools to diagnose, treat, and prevent them.
Among the health conditions that might have faced a setback is leishmaniasis, a parasitic disease associated with poverty. It can cause devastating lifestyle changes, disability, and even death.
There’s a big market for new treatments for TB, malaria and other ailments. But most of these diseases afflict low-income people unable to pay for medicine.
Each year 50 000 people from 89 countries, in every continent except Antarctica, die from leishmaniasis, an ancient neglected disease.
A team of medievalists and scientists look back to history – including a 1,000-year-old eyesalve recipe – for clues to new antibiotics.
Emerging diseases on which the experts are keeping a close eye.
Top contributors
-
Lecturer and Team Leader: Leishmaniasis Research Group, University of Cape Town
-
PhD Candidate, University of Cape Town
-
Researcher, Kenya Medical Research Institute
-
Lecturer, Lancaster University
-
CLIR Postdoctoral Fellow for Data Curation in Medieval Studies, University of Pennsylvania
-
Professor of Chemistry; Interim Chair of the Chemistry Department, University of South Florida
-
Associate Professor of Pharmacy, University of Connecticut
-
Arturo Falaschi ICGEB PhD Fellow, University of Cape Town
